DANA DOLCE: Open Payments
NPI 1548329865 · STANFORD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,863 in 95 payments from 24 companies in 2025. Trend: 2023 $724 · 2024 $1,528 · 2025 $1,863
Food & beverage: $1,863
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 8 | $361 |
| UCB, Inc. | 22 | $347 |
| Medtronic, Inc. | 13 | $193 |
| InSightec,Inc | 3 | $134 |
| Neurelis, Inc. | 6 | $97 |
| ARGENX US, INC. | 5 | $83 |
| SERVIER PHARMACEUTICALS LLC | 4 | $73 |
| Neurocrine BioSciences, Inc. | 4 | $72 |
| Tonix Medicines, Inc. | 4 | $62 |
| Lundbeck LLC | 3 | $52 |
Products named: General - DBS, PERCEPT PC BRAINSENSE, Exablate, Briviact, VALTOCO, Rystiggo, INGREZZA, Fintepla.
Industry payments across CA — which companies pay providers there.
